Format

Send to

Choose Destination
Pediatr Infect Dis J. 2010 Apr;29(4):368-70. doi: 10.1097/INF.0b013e3181c52a04.

Should higher vancomycin trough levels be targeted for invasive community-acquired methicillin-resistant Staphylococcus aureus infections in children?

Author information

1
Department of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, USA.

Abstract

Methicillin-resistant Staphylococcus aureus isolates with vancomycin minimal inhibitory concentrations (MICs) >or=1.5 microg/mL have been associated with poorer clinical outcomes and treatment failures in adults. We evaluated vancomycin MICs in 71 invasive pediatric community-acquired MRSA isolates from 2004 to 2008, using the E-test micromethod and the E-test macro-method. The modal MIC by micromethod was 1.5 microg/mL, and median vancomycin MICs did not increase over time.

PMID:
19935448
PMCID:
PMC3848324
DOI:
10.1097/INF.0b013e3181c52a04
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center